TRUL — Trulieve Cannabis Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousMid CapSuper Stock
- CA$1.39bn
- CA$2.21bn
- $1.24bn
- 75
- 64
- 66
- 77
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.71 | ||
| Price to Tang. Book | 38.54 | ||
| Price to Free Cashflow | 19.84 | ||
| Price to Sales | 0.91 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.26% | ||
| Return on Equity | -24.82% | ||
| Operating Margin | -20.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 102.82 | 252.82 | 521.53 | 937.98 | 1,239.81 | 1,113.83 | 1,113.52 | 128.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +22.39 | -65.51 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company is a multi-state operator in the United States with established hubs in the Northeast, Southeast, and Southwest, anchored by market positions in Arizona, Florida, and Pennsylvania. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, retail and logistics. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, and Roll One.
Directors
- Kim Rivers CHM (42)
- Steven White PRE (47)
- Alex D' Amico CFO (45)
- Ronda Sheffield CHO
- Nilyum Jhala CTO
- Zachary Kobrin GCN
- Kyle Landrum OTH (35)
- Aaron Lopez OTH
- Timothy Morey OTH (58)
- Eric Powers SEC (51)
- Thad Beshears IND (46)
- Peter Healy IND (69)
- Richard May IND (43)
- Thomas Millner IND (67)
- Susan Thronson IND (59)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- September 19th, 2018
- Public Since
- September 25th, 2018
- No. of Employees
- 7,600
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 185,987,512
- Address
- 6749 Ben Bostic Road, QUINCY, 32351
- Web
- Phone
- +1 8502988866
- Auditors
- Marcum LLP
Upcoming Events for TRUL
Q1 2024 Trulieve Cannabis Corp Earnings Release
Similar to TRUL
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Acreage Holdings
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
FAQ
What is the Trulieve Cannabis share price?
As of Today at 18:22 UTC, shares in Trulieve Cannabis are trading at CA$7.48. This share price information is delayed by 15 minutes.
How has the Trulieve Cannabis share price performed this year?
Shares in Trulieve Cannabis last closed at CA$7.48 and the price had moved by -59.57% over the past 365 days. In terms of relative price strength the Trulieve Cannabis share price has underperformed the Toronto Stock Exchange 300 Composite Index by -59.5% over the past year.
What are the analyst and broker recommendations for Trulieve Cannabis?
The overall consensus recommendation for Trulieve Cannabis is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Trulieve Cannabis dividend yield?
Trulieve Cannabis does not currently pay a dividend.
Does Trulieve Cannabis pay a dividend?
Trulieve Cannabis does not currently pay a dividend.
When does Trulieve Cannabis next pay dividends?
Trulieve Cannabis does not currently pay a dividend.
How do I buy Trulieve Cannabis shares?
To buy shares in Trulieve Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Trulieve Cannabis?
As of the previous close price of CA$7.48, shares in Trulieve Cannabis had a market capitalisation of CA$1.39bn.
Where are Trulieve Cannabis shares listed?
Here are the trading details for Trulieve Cannabis:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: TRUL
What kind of share is Trulieve Cannabis?
Based on an overall assessment of its quality, value and momentum Trulieve Cannabis is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Trulieve Cannabis share price forecast for 2023?
The analyst consensus target price for shares in Trulieve Cannabis is CA$17.38. That is 132.41% above the last closing price of CA$7.48.
Analysts covering Trulieve Cannabis currently have a consensus Earnings Per Share (EPS) forecast of -$2.69 for the next financial year.
What is the trend in the Trulieve Cannabis share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Trulieve Cannabis. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +40.18%.
As of the last closing price of CA$7.48, shares in Trulieve Cannabis were trading +9.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Trulieve Cannabis PE Ratio?
The Trulieve Cannabis PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$7.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Trulieve Cannabis?
Trulieve Cannabis' management team is headed by:
- Kim Rivers - CHM
- Steven White - PRE
- Alex D' Amico - CFO
- Ronda Sheffield - CHO
- Nilyum Jhala - CTO
- Zachary Kobrin - GCN
- Kyle Landrum - OTH
- Aaron Lopez - OTH
- Timothy Morey - OTH
- Eric Powers - SEC
- Thad Beshears - IND
- Peter Healy - IND
- Richard May - IND
- Thomas Millner - IND
- Susan Thronson - IND